User profiles for "author:A Castanon"

Alfonso Nieto-Castanon

- Verified email at bu.edu - Cited by 12529

Alejandra Castanon

- Verified email at kcl.ac.uk - Cited by 3342

[HTML][HTML] Cervical screening during the COVID-19 pandemic: optimising recovery strategies

A Castanon, M Rebolj, EA Burger… - The Lancet Public …, 2021 - thelancet.com
Disruptions to cancer screening services have been experienced in most settings as a
consequence of the COVID-19 pandemic. Ideally, programmes would resolve backlogs by …

Anticorrelations in resting state networks without global signal regression

XJ Chai, AN Castañón, D Öngür, S Whitfield-Gabrieli - Neuroimage, 2012 - Elsevier
Anticorrelated relationships in spontaneous signal fluctuation have been previously
observed in resting-state functional magnetic resonance imaging (fMRI). In particular, it was …

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data

P Sasieni, A Castanon, J Cuzick - Bmj, 2009 - bmj.com
Objective To study the effect of cervical screening on incidence of cervical cancer as a
function of age with particular focus on women screened under the age of 25. Design …

The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based …

M Falcaro, A Castañon, B Ndlela, M Checchi, K Soldan… - The Lancet, 2021 - thelancet.com
Background Human papillomavirus (HPV) immunisation with a bivalent vaccine (Cervarix)
was introduced in England, UK, in Sept 1, 2008: routine vaccination was offered to girls …

[HTML][HTML] Impact of cervical screening on cervical cancer mortality: estimation using stage-specific results from a nested case–control study

R Landy, F Pesola, A Castañón, P Sasieni - British journal of cancer, 2016 - nature.com
Background: It is well established that screening can prevent cervical cancer, but the
magnitude of the impact of regular screening on cervical cancer mortality is unknown …

[HTML][HTML] Cervical screening at age 50–64 years and the risk of cervical cancer at age 65 years and older: population-based case control study

A Castanon, R Landy, J Cuzick, P Sasieni - PLoS medicine, 2014 - journals.plos.org
Background There is little consensus, and minimal evidence, regarding the age at which to
stop cervical screening. We studied the association between screening at age 50–64 y and …

Screening and adenocarcinoma of the cervix

P Sasieni, A Castanon, J Cuzick - International journal of …, 2009 - Wiley Online Library
Screening has had a major impact on cervical cancer in many countries. Although there can
be no doubt about its effectiveness in preventing squamous‐cell carcinoma, there is little …

Risk of preterm birth after treatment for cervical intraepithelial neoplasia among women attending colposcopy in England: retrospective-prospective cohort study

A Castanon, P Brocklehurst, H Evans, D Peebles… - Bmj, 2012 - bmj.com
Objective To explore the association between preterm delivery and treatment at colposcopy.
Design Retrospective-prospective cohort study using record linkage. Setting 12 National …

Risk of preterm delivery with increasing depth of excision for cervical intraepithelial neoplasia in England: nested case-control study

A Castanon, R Landy, P Brocklehurst, H Evans… - Bmj, 2014 - bmj.com
Objective To determine the association between depth of excision of cervical intraepithelial
neoplasia and risk of preterm birth. Design Case-control study nested in record linkage …

Head-to-head comparison of the RNA-based aptima human papillomavirus (HPV) assay and the DNA-based hybrid capture 2 HPV test in a routine screening …

T Iftner, S Becker, KJ Neis, A Castanon… - Journal of clinical …, 2015 - Am Soc Microbiol
ABSTRACT Testing for E6/E7 mRNA in cells infected with high-risk (HR) human
papillomavirus (HPV) might improve the specificity of HPV testing for the identification of …